Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
The challenges of measuring disability accumulation in relapsing-remitting multiple sclerosis: evidence from interferon beta treatments.
Secretory IgA Induces Tolerogenic Dendritic Cells through SIGNR1 Dampening Autoimmunity in Mice.
Visualization of acute focal lesions in rats with experimental autoimmune encephalomyelitis by magnetic nanoparticles, comparing different MRI sequences including phase imaging.
Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis.
Relationship between vitamin D deficiency and visually evoked potentials in multiple sclerosis.
The only certain measure of the effectiveness of multiple sclerosis therapy is cerebrospinal neurofilament level-NO.
Best Practices in Alemtuzumab Administration: Practical Recommendations for Infusion in Patients With Multiple Sclerosis.
Analysis of upper limb movement in Multiple Sclerosis subjects during common daily actions.
Genetic inactivation of PERK signaling in mouse oligodendrocytes: Normal developmental myelination with increased susceptibility to inflammatory demyelination.
Cinnabarinic acid, an endogenous agonist of type-4 metabotropic glutamate receptor, suppresses experimental autoimmune encephalomyelitis in mice.
Endometriosis and susceptibility to multiple sclerosis: is there any absolute truth?
A GPBAR1 (TGR5) Small Molecule Agonist Shows Specific Inhibitory Effects on Myeloid Cell Activation In Vitro and Reduces Experimental Autoimmune Encephalitis (EAE) In Vivo.
Association between smoking and cognitive impairment in multiple sclerosis.
Correction: deep gray matter demyelination detected by magnetization transfer ratio in the cuprizone model.
Uhthoff phenomenon in osmotic demyelination syndrome.
Histogram analysis of apparent diffusion coefficient maps for differentiating primary CNS lymphomas from tumefactive demyelinating lesions.
The Anti-Aging Protein Klotho Enhances Remyelination Following Cuprizone-Induced Demyelination.
'You are just left to get on with it': qualitative study of patient and carer experiences of the transition to secondary progressive multiple sclerosis.
Optic neuritis: Experience from a south Indian demyelinating disease registry.
Stoppers and non-starters of disease-modifying treatment in multiple sclerosis.
Protective effects of 27- and 24-hydroxycholesterol against staurosporine-induced cell death in undifferentiated neuroblastoma SH-SY5Y cells.
Complement-dependent pathogenicity of brain-specific antibodies in cerebrospinal fluid.
Comprehensive analysis of microRNA profiles in multiple sclerosis including next-generation sequencing.
Layered genetic control of DNA methylation and gene expression: a locus of multiple sclerosis in healthy individuals.
Cognitive-motor related brain activity during walking: differences between men and women with multiple sclerosis.
Pages
« first
‹ previous
…
476
477
478
479
480
481
482
483
484
…
next ›
last »